University of Cape Coast Institutional Repository

The role of trust in a self-organizing pharmaceutical supply chain model with variable drug quality and imperfect information

Show simple item record

dc.contributor.author Auckland, Graeme J.
dc.contributor.author Chattoe-Brown, Edmund
dc.contributor.author Heather, Hamill
dc.contributor.author Hampshire, Kate R.
dc.contributor.author Mariwah, Simon
dc.contributor.author Mshana, Gerry
dc.date.accessioned 2022-01-25T12:01:01Z
dc.date.available 2022-01-25T12:01:01Z
dc.date.issued 2019-03-31
dc.identifier.issn 23105496
dc.identifier.uri http://hdl.handle.net/123456789/7394
dc.description 17p:, ill. en_US
dc.description.abstract We present an Agent-Based Model (herea er ABM) for a pharmaceutical supply chain operating under conditions of weak regulation and imperfect information, exploring the possibility of poor qualitymedicines and their detection. Our interest is to demonstrate how buyers can learn about the quality of sellers (and their medicines) based on previous successful and unsuccessful transactions, thereby establishing trust over time. Furthermore, this network of trust allows the system itself to evolve to positive outcomes (under some but not all circumstances) by eliminating sellers with low quality products. The ABM we develop assumes that rational and non-corrupt agents (wholesalers, retailers and consumers) learn from experience and adjust their behaviour accordingly. The system itself evolves over time: under some — but not all — circumstances, sellers with low-quality products are progressively eliminated. Three distinct states of the supply chain are observed depending on the importance of trust built up from past experience. The “dynamic” state is characterised by a low level of trust leading to a continually changing system with new drugs introduced and rejected with little regard to quality. The “frozen” state arises from high levels of reliance on past experience and locks the supply chain into a suboptimal state. The “optimising” state has moderate reliance on past experience and leads to the persistence of suppliers with good quality; however, the system is still “invadable” by better quality drugs. Simulation results show that the state reached by the system depends strongly on the precise way that trust is established: Excessive levels of trust make it impossible for new, improved treatments to be adopted. This highlights the critical need to understand better how personal experience influences consumer behaviour, especially where regulation is weak and for products like medicines whose quality is not readily observable en_US
dc.language.iso en en_US
dc.publisher University of Cape Coast en_US
dc.subject Trust en_US
dc.subject Africa en_US
dc.subject Supply chain en_US
dc.subject Self-organization en_US
dc.subject Drugs en_US
dc.subject Medicine en_US
dc.title The role of trust in a self-organizing pharmaceutical supply chain model with variable drug quality and imperfect information en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search UCC IR


Advanced Search

Browse

My Account